Key Takeaway
After 6 months on Wegovy, most patients lose 20 to 35 pounds at the full 2.4 mg dose. Here is a complete timeline with STEP trial data and practical tips.
Six months on Wegovy is when the medication truly delivers on its promise. If you're researching Wegovy results after 6 months, you'll find impressive numbers: most patients have lost 20 to 35 pounds, representing 9% to 14% of their starting body weight . By now, you have been at the full 2.4 mg maintenance dose for about four weeks, and the medication is at peak effectiveness.
The Full 2.4 mg Dose: Peak Efficacy
After completing the five-step titration (0.25 to 0.5 to 1.0 to 1.7 to 2.4 mg), you reached the maintenance dose in month five. Month six is typically your first full month at 2.4 mg .
At 2.4 mg, semaglutide produces its strongest effects on appetite, gastric emptying, and metabolic function. Patients typically describe this dose level as providing effortless appetite control, where eating less happens naturally without mental struggle.
Six-Month Results by the Numbers
| Metric | Typical Result at 6 Months |
|---|---|
| Total weight loss | 20 to 35 pounds |
| Body weight percentage | 9% to 14% |
| Waist circumference | 3.5 to 6 inches lost |
| Blood pressure | 8 to 14 mmHg systolic decrease |
| Triglycerides | 15% to 30% decrease |
| Fasting insulin | 20% to 40% decrease |
The landmark STEP 1 trial[1] showed 12.4% body weight loss at week 24 on average for the semaglutide 2.4 mg group, with the study going on to show 14.9% loss at week 68 . At six months, you're solidly on that trajectory. For a complete cost breakdown, see our cheapest semaglutide options.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Beyond the Scale: thorough Health Changes
- Cardiovascular risk: The SELECT trial[2] proved that semaglutide reduces major cardiovascular events by 20% in at-risk patients. Your improved blood pressure, lipids, and glucose all contribute to lower heart disease risk .
- Diabetes prevention: Patients with prediabetes often see fasting glucose and A1C return to normal ranges, potentially preventing the progression to type 2 diabetes.
- Joint health: 25+ pounds of weight reduction significantly reduces stress on knees, hips, and spine.
- Sleep quality: Improved breathing during sleep, reduced snoring, and resolution of mild sleep apnea for many patients.
- Mental wellbeing: Greater confidence, reduced food anxiety, and improved body image.
Side Effects at Six Months
At the maintenance dose, most patients have adapted well :
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- GI effects: Minimal for most patients at stable doses. Eating too much or too fast may cause temporary discomfort.
- Constipation: Managed with ongoing fiber and hydration routine.
- Nutritional concerns: Reduced food intake requires intentional nutrient-dense eating to prevent deficiencies.
- Hair shedding: If present, typically begins to resolve around month 6 as weight loss rate slows.
- Skin changes: Patients with 30+ pounds of loss may notice skin laxity in areas like the abdomen and upper arms.
Planning the Next Phase
- Continue or adjust? Most patients benefit from continuing Wegovy beyond six months. Discuss your trajectory with your provider.
- Lab work. Full metabolic panel, lipids, vitamin levels, and thyroid function.
- Fitness goals. Shift focus from weight loss to body composition, strength, and cardiovascular fitness.
- Psychological support. Major physical transformation sometimes benefits from professional counseling or coaching.
- Long-term budgeting. Plan for continued treatment costs. Compounded semaglutide may offer savings FormBlends pricing.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
Will weight loss continue after 6 months on Wegovy?
Yes. The STEP trials showed continued weight loss through month 15 to 17. The rate slows gradually but doesn't stop immediately at six months Wegovy results after 9 months.
Can I lower my Wegovy dose after 6 months?
Some patients can maintain results at 1.7 mg. But dose reduction carries a risk of weight regain. Any dose change should be done under medical supervision .
Is 20 to 35 pounds of loss clinically significant?
Absolutely. Losing 10% or more of body weight is associated with significant reductions in the risk of type 2 diabetes, cardiovascular disease, certain cancers, and overall mortality .
What if I want to get pregnant?
Wegovy should be stopped at least 2 months before attempting pregnancy. Discuss family planning with your provider well in advance .
How does Wegovy at 6 months compare to bariatric surgery?
Bariatric surgery typically produces greater total weight loss (25% to 35% of body weight) compared to Wegovy (15% average). But Wegovy avoids surgical risks and is reversible. Some patients use GLP-1 medications as an alternative to surgery .